Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Diseases
Human papillomavirus (HPV)
Diseases
Human papillomavirus (HPV)
SAGE recommendations and background documents
Find out more
2022
∙
SAGE
Should an off-label , permissive one-dose HPV vaccine schedule for use in routine and/or multi-age cohort (MAC) catch up strategies be recommended?
Download:
EN
GRADE table
Human papillomavirus (HPV)
2022
∙
SAGE
Human papillomavirus vaccines: WHO position paper, December 2022
Download:
EN
Position paper
Human papillomavirus (HPV)
2018
∙
WHO
Summary of WHO Position Papers - Recommended Routine Immunizations for Children
Download:
EN
FR
Position paper
Human papillomavirus (HPV)
2017
∙
SAGE
In 9 to 15-year old females, is 9-valent human papillomavirus vaccine (HPV) vaccine superior to 4-valent or 2-valent HPV vaccines?
Download:
EN
Evidence to recommendation table
Human papillomavirus (HPV)
2017
∙
SAGE
What is the incremental effectiveness and cost-effectiveness of vaccinating multiple age cohorts versus a single age cohort in high income countries (HIC) and low and middle income countries (LMIC)?
Download:
EN
Evidence to recommendation table
Human papillomavirus (HPV)
2017
∙
SAGE
What is the public health impact on cervical cancer of administering HPV vaccine to 9 to 15-year old females and males versus to 9 to 15-year old females?
Download:
EN
Evidence to recommendation table
Human papillomavirus (HPV)
2017
∙
SAGE
Efficacy of HPV vaccination in HIV infected girls
Download:
EN
GRADE table
Human papillomavirus (HPV)
2017
∙
SAGE
Safety of HPV vaccination in HIV infected girls
Download:
EN
GRADE table
Human papillomavirus (HPV)
2017
∙
SAGE
Protection of anogenital warts conferred by HPV vaccination in immunocompetent girls
Download:
EN
GRADE table
Human papillomavirus (HPV)
External links
HPV Vaccine Introduction Clearing House
Link:
EN
HPV introduction Dashboard
Link:
EN
HPV Vaccine Schedule Optimization — Key Considerations for Decision-Making, Planning and Implementation
Link:
EN
Human papillomavirus (HPV) vaccine market shaping roadmap
Link:
EN
Global strategy to accelerate the elimination of cervical cancer as a public health problem
Link:
EN
Considerations for human papillomavirus (HPV) vaccine product choice
Link:
EN
Home
Resources
Diseases
Training
SYSVAC
News
Events
Webinars
Network
Sign in / Register
